SV2 PET Imaging With [11C]APP311
Recruiting
Observational Study
Schizophrenia and Other Psychotic Disorders
Cannabis Use Disorder
Healthy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Yale University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to evaluate a new SV2A tracer, \[11C\]APP311, in healthy aging and neuropsychiatric disorders including psychotic disorders and cannabis use disorders.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Willing and able to give voluntary written informed consent
* Male and Female subjects, age 18 to 65 years, inclusive
Exclusion Criteria:
* MRI metal exclusions and claustrophobia.
* Education completed is less than 12 years
Contacts